Volunteers sought for bird flu vaccine trial
The University of Nottingham is participating in a national trial testing a new bird flu vaccine, using mRNA technology similar to Covid jabs. The trial will involve 3,000 adults in the UK to examine the vaccine's safety and effectiveness against the H5N1 flu strain.
The University of Nottingham is helping to deliver a national trial for a new bird flu vaccine. The vaccine targets the H5N1 flu strain, which has caused significant infections in bird populations and has spread to some mammals. The trial will involve around 3,000 adults in the UK and will assess the vaccine's safety and ability to generate a strong immune response. Nottingham will be one of 26 sites across the UK administering the vaccine. The vaccine uses mRNA technology, similar to current Covid jabs, allowing for quick and scaled production in the event of a pandemic. There have been 116 confirmed human cases worldwide since 2024, mostly linked to close contact with infected animals.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.